• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by TD SYNNEX Corporation

    5/29/25 4:01:29 PM ET
    $SNX
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $SNX alert in real time by email
    SD 1 tdsnxconflictmineralsforms.htm SD Document


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    _______________________________

    FORM SD
    Specialized Disclosure Report

    _______________________________

    TD SYNNEX CORPORATION
    (Exact name of registrant as specified in its charter)

    _______________________________


    Delaware
    001-31892
    94-2703333
    (State or other jurisdiction of
    incorporation)
    (Commission
    File Number)
    (I.R.S. Employer
    Identification No.)

    44201 Nobel Drive
    Fremont, California
    94538
    (Address of principal executive offices)
    (Zip Code)

    David Vetter
    Chief Legal Officer and Corporate Secretary
    (727) 538-7062
    (Name and telephone number, including area code, of the person to contact in connection with this report.)

    Check the appropriate box to indicate the rule pursuant to which this Form is being submitted, and provide the period to which the information in this Form applies:

    ☒
    Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.
    ☐
    Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended _____________.





    Section 1 – Conflict Minerals Disclosure

    Item 1.01
    Conflict Minerals Disclosure and Report
    As provided for in Rule 13p-1 under the Securities Exchange Act of 1934, as amended, and Form SD, a Conflict Minerals Report is provided as an exhibit to this Form SD and is available at https://ir.tdsynnex.com/financials/default.aspx#section=sec-filings. The information contained on our website is not incorporated by reference into this Form SD or our Conflict Minerals Report and should not be considered part of this Form SD or the Conflict Minerals Report.

    Item 1.02
    Exhibit
    The Conflict Minerals Report described in Item 1.01 is filed as Exhibit 1.01 to this Form SD.

    Section 3 – Exhibits

    Item 3.01
    Exhibits

    Exhibit No.
    Description
    1.01
    Conflict Minerals Report for the calendar year ended December 31, 2024.






    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
    TD SYNNEX CORPORATION
    By: /s/ David Vetter         Date: May 29, 2025
    David Vetter
    Chief Legal Officer and Corporate Secretary









    Get the next $SNX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNX

    DatePrice TargetRatingAnalyst
    6/11/2025$145.00Overweight
    Morgan Stanley
    3/20/2025$138.00 → $156.00Outperform
    Barrington Research
    7/15/2024$135.00 → $140.00Sector Perform → Outperform
    RBC Capital Mkts
    4/16/2024$115.00 → $145.00Neutral → Buy
    UBS
    1/8/2024$112.00 → $113.00Overweight → Neutral
    JP Morgan
    11/22/2023$105.00Neutral
    UBS
    5/1/2023$101.00Buy
    Goldman
    2/15/2023$109.00Equal Weight
    Barclays
    More analyst ratings